These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 6831420

  • 21. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q.
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [Abstract] [Full Text] [Related]

  • 22. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K, Cornelius SC, Danielpour D.
    Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605
    [Abstract] [Full Text] [Related]

  • 23. The Nb rat prostatic adenocarcinoma model system.
    Drago JR, Goldman LB, Maurer RE.
    Prog Clin Biol Res; 1980 Aug 01; 37():265-91. PubMed ID: 7384086
    [Abstract] [Full Text] [Related]

  • 24. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.
    Int J Oncol; 2004 Mar 01; 24(3):461-71. PubMed ID: 14767530
    [Abstract] [Full Text] [Related]

  • 25. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 Mar 01; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 26. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW, Lau KW, Tam PC, Shiu SY.
    Prostate; 2002 Jul 01; 52(2):106-22. PubMed ID: 12111702
    [Abstract] [Full Text] [Related]

  • 27. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth.
    van Steenbrugge GJ, Groen M, Bolt-de Vries J, Romijn JC, Schroeder FH.
    Prog Clin Biol Res; 1985 Jul 01; 185A():23-50. PubMed ID: 4034577
    [No Abstract] [Full Text] [Related]

  • 28. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
    Gleave ME, Sato N, Sadar M, Yago V, Bruchovsky N, Sullivan L.
    J Cell Biochem; 1998 Jun 01; 69(3):271-81. PubMed ID: 9581866
    [Abstract] [Full Text] [Related]

  • 29. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M.
    Cancer Res; 2003 Jan 01; 63(1):149-53. PubMed ID: 12517791
    [Abstract] [Full Text] [Related]

  • 30. Establishment of two human prostate cancer cell lines derived from a single bone metastasis.
    Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2493-500. PubMed ID: 9815652
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a transplantable hormone-responsive human prostatic cancer xenograft TEN12 and its androgen-resistant sublines.
    Harper ME, Goddard L, Smith C, Nicholson RI.
    Prostate; 2004 Jan 01; 58(1):13-22. PubMed ID: 14673948
    [Abstract] [Full Text] [Related]

  • 32. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J, Arnold JT, Isaacs JT.
    Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338
    [Abstract] [Full Text] [Related]

  • 33. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

  • 34. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations.
    Karan D, Schmied BM, Dave BJ, Wittel UA, Lin MF, Batra SK.
    Clin Cancer Res; 2001 Nov 01; 7(11):3472-80. PubMed ID: 11705865
    [Abstract] [Full Text] [Related]

  • 35. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM.
    Cancer Res; 2001 Apr 01; 61(7):2892-8. PubMed ID: 11306464
    [Abstract] [Full Text] [Related]

  • 36. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
    Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW.
    Cancer Res; 1994 May 15; 54(10):2577-81. PubMed ID: 8168083
    [Abstract] [Full Text] [Related]

  • 37. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T, Nakamura K, Araki H, Kusaka M, Yamaoka M.
    Cancer Res; 2003 Sep 01; 63(17):5622-8. PubMed ID: 14500404
    [Abstract] [Full Text] [Related]

  • 38. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE, Isaacs JT.
    Cancer Res; 1982 Aug 01; 42(8):3148-56. PubMed ID: 7093958
    [Abstract] [Full Text] [Related]

  • 39. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
    Lee SO, Pinder E, Chun JY, Lou W, Sun M, Gao AC.
    Prostate; 2008 Jan 01; 68(1):85-91. PubMed ID: 18008330
    [Abstract] [Full Text] [Related]

  • 40. UM-SCP-1, a new human cell line derived from a prostatic squamous cell carcinoma.
    Grossman HB, Wedemeyer G, Ren L, Carey TE.
    Cancer Res; 1984 Sep 01; 44(9):4111-7. PubMed ID: 6378378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.